Literature DB >> 16788292

Immunology of Helicobacter pylori infection.

Dominique Velin1, Pierre Michetti.   

Abstract

Helicobacter pylori is a Gram-negative, spiral bacterium that colonizes the gastric mucosa of at least 50% of the world's population and plays a causative role in the development of chronic gastritis as well as in gastric and duodenal ulcers. H. pylori triggers vigorous humoral and cellular immune responses in both systemic and mucosal compartments. In spite of this response, the vast majority of infected hosts are unable to clear the infection, and it persists for decades. Although Helicobacter is tolerated by a naïve host organism, preclinical studies have demonstrated that prophylactic or therapeutic vaccinations efficiently clear Helicobacter from the stomach. The understanding of the mechanisms leading to the Helicobacter persistence or the vaccine-induced eradication of Helicobacter in animal models will help to define optimal immunization strategies for future anti-Helicobacter vaccination clinical trials. Copyright 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16788292     DOI: 10.1159/000094043

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  6 in total

1.  Activation of CD3+ T cells by Helicobacter pylori DNA vaccines in potential immunotherapy of gastric carcinoma.

Authors:  Li-Jun Xue; Xiao-Bei Mao; Xiao-Bei Liu; Han Gao; Ya-Nan Chen; Ting-Ting Dai; Sheng-Wen Shao; Hong-Min Chen; Xiao-Yuan Chu
Journal:  Cancer Biol Ther       Date:  2019-02-20       Impact factor: 4.742

2.  Comprehensive Analysis of PDLIM3 Expression Profile, Prognostic Value, and Correlations with Immune Infiltrates in Gastric Cancer.

Authors:  Xinpeng Hu; Minfeng Chen; Qiang Ruan; Changzheng Shi; Jinghua Pan; Liangping Luo
Journal:  J Immunol Res       Date:  2022-05-12       Impact factor: 4.493

3.  Cutting Edge: Expression of IRF8 in Gastric Epithelial Cells Confers Protective Innate Immunity against Helicobacter pylori Infection.

Authors:  Ming Yan; Hongsheng Wang; Jiafang Sun; Wei Liao; Peng Li; Yin Zhu; Chengfu Xu; Jungsoo Joo; Yan Sun; Sadia Abbasi; Alexander Kovalchuk; Nonghua Lv; Warren J Leonard; Herbert C Morse
Journal:  J Immunol       Date:  2016-02-03       Impact factor: 5.422

4.  Helicobacter pylori, HIV and Gastric Hypochlorhydria in the Malawian Population.

Authors:  Joe Geraghty; Alexander Thumbs; Anstead Kankwatira; Tim Andrews; Andrew Moore; Rose Malamba; Neema Mtunthama; Kai Hellberg; Lughano Kalongolera; Paul O'Toole; Andrea Varro; D Mark Pritchard; Melita Gordon
Journal:  PLoS One       Date:  2015-08-05       Impact factor: 3.240

5.  Gastric cancer progression associated with local humoral immune responses.

Authors:  López-Vidal Yolanda; Ponce-de-León Sergio; Esquivel-Solís Hugo; Amieva-Fernández Rosa Isabel; Barreto-Zúñiga Rafael; Torre-Delgadillo Aldo; Castillo-Rojas Gonzalo
Journal:  BMC Cancer       Date:  2015-11-21       Impact factor: 4.430

Review 6.  Helicobacter pylori: Perturbation and restoration of gut microbiome.

Authors:  Ankita Saxena; Asish Kumar Mukhopadhyay; Shoma Paul Nandi
Journal:  J Biosci       Date:  2020       Impact factor: 1.826

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.